SPERANZA project: HPV vaccination after treatment for CIN2+
Top Cited Papers
- 6 September 2018
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 151 (2), 229-234
- https://doi.org/10.1016/j.ygyno.2018.08.033
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil™ in Adult WomenPLOS ONE, 2013
- Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)?Gynecologic Oncology, 2013
- Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort studyInternational Journal of Cancer, 2013
- Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial dataBMJ, 2012
- Prevention of Recurrent High-Grade Anal Neoplasia With Quadrivalent Human Papillomavirus Vaccination of Men Who Have Sex With Men: A Nonconcurrent Cohort StudyClinical Infectious Diseases, 2012
- Association of interleukin-6 in women with persistence of DNA-HPV: a nested case–control studyArchiv für Gynäkologie, 2011
- Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infectionHuman Vaccines, 2009
- Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trialThe Lancet, 2009
- Interferon-γ (IFN-γ): A possible prognostic marker for clearance of high-risk human papillomavirus (HPV)Gynecologic Oncology, 2008
- Human papillomavirus vaccinesReviews in Medical Virology, 2006